Clinical Trials
5 trialsNCT06533657 2026-04-21
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2 Completed
NCT06731894 2025-12-05
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
City of Hope Medical Center
Phase 2 Recruiting
NCT03948074 2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2 Completed
NCT06518434 2024-07-24
CanHep
University Medical Center Groningen
Phase 2 Recruiting
NCT00316563 2010-02-09
Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
AHS Cancer Control Alberta
Phase 2 Completed